Can we use gonadotropin plasma concentration as surrogate marker for BMI-related incomplete estrogen suppression in breast cancer patients receiving anastrozole?
Journal article published in 2017 by
A. Oberguggenberger,
V. Meraner,
M. Sztankay,
B. Beer,
G. Weigel,
H. Oberacher,
G. Kemmler,
T. Czech,
B. Holzner,
L. Wildt,
B. Sperner-Unterweger 
,
M. Daniaux,
M. Hubalek
,
M. Daniaux,
M. Hubalek
This paper is made freely available by the publisher.
Full text: Download
Data provided by 